Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Status of .

International journal of human genetics

Ghosh S, Trnovec T, Palkovicova L, Hoffman EP, Washington K, Dutta SK.
PMID: 23741107
Int J Hum Genet. 2013 Mar;13(1):27-32. doi: 10.1080/09723757.2013.11886193.

Earlier, we have reported that Polychlorinated Biphenyls (PCBs) exposure in Slovak population has made differential gene expression that has linked to the possibilities of some diseases and disorder development in the studied population. Here we report that down-regulation of...

Cite
Ghosh S, Trnovec T, Palkovicova L, et al. Status of . Int J Hum Genet. 2013;13(1):27-32doi: 10.1080/09723757.2013.11886193.
Ghosh, S., Trnovec, T., Palkovicova, L., Hoffman, E. P., Washington, K., & Dutta, S. K. (2013). Status of . International journal of human genetics, 13(1), 27-32. https://doi.org/10.1080/09723757.2013.11886193
Ghosh, Somiranjan, et al. "Status of ." International journal of human genetics vol. 13,1 (2013): 27-32. doi: https://doi.org/10.1080/09723757.2013.11886193
Ghosh S, Trnovec T, Palkovicova L, Hoffman EP, Washington K, Dutta SK. Status of . Int J Hum Genet. 2013 Mar;13(1):27-32. doi: 10.1080/09723757.2013.11886193. PMID: 23741107; PMCID: PMC3670706.
Copy Download .nbib Format: NLM
Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin).

Thyroid research

Langer P, Kocan A, Tajtáková M, Susienková K, Rádiková Z, Koska J, Ksinantová L, Imrich R, Hucková M, Drobná B, Gasperíková D, Trnovec T, Klimes I.
PMID: 19335881
Thyroid Res. 2009 Mar 31;2(1):3. doi: 10.1186/1756-6614-2-3.

BACKGROUND: Several our previous studies showed associations of increasing blood level of persistent organochlorinated pollutants (POPs) with individual thyroid and metabolic adverse health signs in subjects from heavily polluted area (POLL) compared to these from the area of background...

Cite
Langer P, Kocan A, Tajtáková M, et al. Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin). Thyroid Res. 2009;2(1):3doi: 10.1186/1756-6614-2-3.
Langer, P., Kocan, A., Tajtáková, M., Susienková, K., Rádiková, Z., Koska, J., Ksinantová, L., Imrich, R., Hucková, M., Drobná, B., Gasperíková, D., Trnovec, T., & Klimes, I. (2009). Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin). Thyroid research, 2(1), 3. https://doi.org/10.1186/1756-6614-2-3
Langer, Pavel, et al. "Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin)." Thyroid research vol. 2,1 (2009): 3. doi: https://doi.org/10.1186/1756-6614-2-3
Langer P, Kocan A, Tajtáková M, Susienková K, Rádiková Z, Koska J, Ksinantová L, Imrich R, Hucková M, Drobná B, Gasperíková D, Trnovec T, Klimes I. Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin). Thyroid Res. 2009 Mar 31;2(1):3. doi: 10.1186/1756-6614-2-3. PMID: 19335881; PMCID: PMC2679721.
Copy Download .nbib Format: NLM
Exposure to polychlorinated biphenyls and hearing impairment in children.

Environmental toxicology and pharmacology

Trnovec T, Sovčíková E, Hust'ák M, Wimmerová S, Kočan A, Jurečková D, Langer P, Palkovičová L, Drobná B.
PMID: 21783857
Environ Toxicol Pharmacol. 2008 Mar;25(2):183-7. doi: 10.1016/j.etap.2007.10.030. Epub 2007 Oct 24.

The objective of this cross-sectional epidemiological study was to assess if long-term exposure to polychlorinated biphenyls (PCBs) is associated with hearing impairment. Four hundred and thirty-three children aged 8-9 years residing in an area polluted by PCBs in Eastern...

Cite
Trnovec T, Sovčíková E, Hust'ák M, et al. Exposure to polychlorinated biphenyls and hearing impairment in children. Environ Toxicol Pharmacol. 2007;25(2):183-7doi: 10.1016/j.etap.2007.10.030.
Trnovec, T., Sovčíková, E., Hust'ák, M., Wimmerová, S., Kočan, A., Jurečková, D., Langer, P., Palkovičová, L., & Drobná, B. (2008). Exposure to polychlorinated biphenyls and hearing impairment in children. Environmental toxicology and pharmacology, 25(2), 183-7. https://doi.org/10.1016/j.etap.2007.10.030
Trnovec, Tomáš, et al. "Exposure to polychlorinated biphenyls and hearing impairment in children." Environmental toxicology and pharmacology vol. 25,2 (2008): 183-7. doi: https://doi.org/10.1016/j.etap.2007.10.030
Trnovec T, Sovčíková E, Hust'ák M, Wimmerová S, Kočan A, Jurečková D, Langer P, Palkovičová L, Drobná B. Exposure to polychlorinated biphenyls and hearing impairment in children. Environ Toxicol Pharmacol. 2008 Mar;25(2):183-7. doi: 10.1016/j.etap.2007.10.030. Epub 2007 Oct 24. PMID: 21783857.
Copy Download .nbib Format: NLM
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

PloS one

Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Sertić J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP.
PMID: 28207884
PLoS One. 2017 Feb 16;12(2):e0172595. doi: 10.1371/journal.pone.0172595. eCollection 2017.

[This corrects the article DOI: 10.1371/journal.pone.0162866.].

Cite
Mizzi C, Dalabira E, Kumuthini J, et al. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One. 2017;12(2):e0172595doi: 10.1371/journal.pone.0172595.
Mizzi, C., Dalabira, E., Kumuthini, J., Dzimiri, N., Balogh, I., Başak, N., Böhm, R., Borg, J., Borgiani, P., Bozina, N., Bruckmueller, H., Burzynska, B., Carracedo, A., Cascorbi, I., Deltas, C., Dolzan, V., Fenech, A., Grech, G., Kasiulevicius, V., Kádaši, �. �., Kučinskas, V., Khusnutdinova, E., Loukas, Y. L., Macek, M., Makukh, H., Mathijssen, R., Mitropoulos, K., Mitropoulou, C., Novelli, G., Papantoni, I., Pavlovic, S., Saglio, G., Sertić, J., Stojiljkovic, M., Stubbs, A. P., Squassina, A., Torres, M., Turnovec, M., van Schaik, R. H., Voskarides, K., Wakil, S. M., Werk, A., Del Zompo, M., Zukic, B., Katsila, T., Lee, M. T., Motsinger-Rief, A., Mc Leod, H. L., van der Spek, P. J., & Patrinos, G. P. (2017). Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PloS one, 12(2), e0172595. https://doi.org/10.1371/journal.pone.0172595
Mizzi, Clint, et al. "Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics." PloS one vol. 12,2 (2017): e0172595. doi: https://doi.org/10.1371/journal.pone.0172595
Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Sertić J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One. 2017 Feb 16;12(2):e0172595. doi: 10.1371/journal.pone.0172595. eCollection 2017. PMID: 28207884; PMCID: PMC5313168.
Copy Download .nbib Format: NLM
Effects of Bioinsecticidal Aegerolysin-Based Cytolytic Complexes on Non-Target Organisms.

Toxins

Panevska A, Glavan G, Jemec Kokalj A, Kukuljan V, Trobec T, Žužek MC, Vrecl M, Drobne D, Frangež R, Sepčić K.
PMID: 34208927
Toxins (Basel). 2021 Jun 30;13(7). doi: 10.3390/toxins13070457.

Aegerolysin proteins ostreolysin A6 (OlyA6), pleurotolysin A2 (PlyA2) and erylysin A (EryA) produced by the mushroom genus

Cite
Panevska A, Glavan G, Jemec Kokalj A, et al. Effects of Bioinsecticidal Aegerolysin-Based Cytolytic Complexes on Non-Target Organisms. Toxins (Basel). 2021;13(7)doi: 10.3390/toxins13070457.
Panevska, A., Glavan, G., Jemec Kokalj, A., Kukuljan, V., Trobec, T., Žužek, M. C., Vrecl, M., Drobne, D., Frangež, R., & Sepčić, K. (2021). Effects of Bioinsecticidal Aegerolysin-Based Cytolytic Complexes on Non-Target Organisms. Toxins, 13(7), . https://doi.org/10.3390/toxins13070457
Panevska, Anastasija, et al. "Effects of Bioinsecticidal Aegerolysin-Based Cytolytic Complexes on Non-Target Organisms." Toxins vol. 13,7 (2021). doi: https://doi.org/10.3390/toxins13070457
Panevska A, Glavan G, Jemec Kokalj A, Kukuljan V, Trobec T, Žužek MC, Vrecl M, Drobne D, Frangež R, Sepčić K. Effects of Bioinsecticidal Aegerolysin-Based Cytolytic Complexes on Non-Target Organisms. Toxins (Basel). 2021 Jun 30;13(7). doi: 10.3390/toxins13070457. PMID: 34208927; PMCID: PMC8310125.
Copy Download .nbib Format: NLM
Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from .

Journal of natural products

Safa N, Trobec T, Holland DC, Slazak B, Jacobsson E, Hawkes JA, Frangež R, Sepčić K, Göransson U, Moodie LWK, Robertson LP.
PMID: 34910498
J Nat Prod. 2021 Dec 15; doi: 10.1021/acs.jnatprod.1c00980. Epub 2021 Dec 15.

During a research program to identify new cholinesterase inhibitors of natural origin, two new 7,8-didehydroprotoberberine alkaloids (

Cite
Safa N, Trobec T, Holland DC, et al. Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from . J Nat Prod. 2021;doi: 10.1021/acs.jnatprod.1c00980.
Safa, N., Trobec, T., Holland, D. C., Slazak, B., Jacobsson, E., Hawkes, J. A., Frangež, R., Sepčić, K., Göransson, U., Moodie, L. W. K., & Robertson, L. P. (2021). Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from . Journal of natural products, . https://doi.org/10.1021/acs.jnatprod.1c00980
Safa, Neda, et al. "Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from ." Journal of natural products vol. (2021). doi: https://doi.org/10.1021/acs.jnatprod.1c00980
Safa N, Trobec T, Holland DC, Slazak B, Jacobsson E, Hawkes JA, Frangež R, Sepčić K, Göransson U, Moodie LWK, Robertson LP. Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from . J Nat Prod. 2021 Dec 15; doi: 10.1021/acs.jnatprod.1c00980. Epub 2021 Dec 15. PMID: 34910498.
Copy Download .nbib Format: NLM
Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes.

Biomedicines

Trobec T, Sepčić K, Žužek MC, Kladnik J, Podjed N, Cardoso Páscoa C, Turel I, Frangež R.
PMID: 34572429
Biomedicines. 2021 Sep 16;9(9). doi: 10.3390/biomedicines9091243.

Cholinesterases (ChEs) show increased activities in patients with Alzheimer's disease, and remain one of the main therapeutic targets for treatment of this neurodegenerative disorder. A library of organoruthenium(II) complexes was prepared to investigate the influence of their structural elements...

Cite
Trobec T, Sepčić K, Žužek MC, et al. Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes. Biomedicines. 2021;9(9)doi: 10.3390/biomedicines9091243.
Trobec, T., Sepčić, K., Žužek, M. C., Kladnik, J., Podjed, N., Cardoso Páscoa, C., Turel, I., & Frangež, R. (2021). Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes. Biomedicines, 9(9), . https://doi.org/10.3390/biomedicines9091243
Trobec, Tomaž, et al. "Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes." Biomedicines vol. 9,9 (2021). doi: https://doi.org/10.3390/biomedicines9091243
Trobec T, Sepčić K, Žužek MC, Kladnik J, Podjed N, Cardoso Páscoa C, Turel I, Frangež R. Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes. Biomedicines. 2021 Sep 16;9(9). doi: 10.3390/biomedicines9091243. PMID: 34572429; PMCID: PMC8467340.
Copy Download .nbib Format: NLM
[In Process Citation].

Bratislavske lekarske listy

Cagan S, Trnovec T.
PMID: 9664733
Bratisl Lek Listy. 1998 Mar;99(3):131-7.

Project Audit of diagnostic and therapeutic procedures in patients with acute coronary syndromes was approved by the Ministry of Health of the Slovak Republic on 13 May 1996. The essence of the project resides in a systematic and complex...

Cite
Cagan S, Trnovec T. Audit of cardiovascular diseases. [In Process Citation]. Bratisl Lek Listy. 1998;99(3):131-7
Cagan, S., & Trnovec, T. (1998). Audit of cardiovascular diseases. [In Process Citation]. Bratislavske lekarske listy, 99(3), 131-7.
Cagan, and Trnovec. "Audit of cardiovascular diseases." [In Process Citation]. Bratislavske lekarske listy vol. 99,3 (1998): 131-7.
Cagan S, Trnovec T. Audit of cardiovascular diseases. [In Process Citation]. Bratisl Lek Listy. 1998 Mar;99(3):131-7. Czech. PMID: 9664733.
Copy Download .nbib Format: NLM
WITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort.

Neurotoxicology

Park HY, Hertz-Picciotto I, Sovcikova E, Kocan A, Trnovec T.
PMID: 19647017
Neurotoxicology. 2009 Jul 30; doi: 10.1016/j.neuro.2009.07.015. Epub 2009 Jul 30.

This article has been withdrawn at the request of the editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Park HY, Hertz-Picciotto I, Sovcikova E, et al. WITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort. Neurotoxicology. 2009;doi: 10.1016/j.neuro.2009.07.015.
Park, H. Y., Hertz-Picciotto, I., Sovcikova, E., Kocan, A., & Trnovec, T. (2009). WITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort. Neurotoxicology, . https://doi.org/10.1016/j.neuro.2009.07.015
Park, Hye-Youn, et al. "WITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort." Neurotoxicology vol. (2009). doi: https://doi.org/10.1016/j.neuro.2009.07.015
Park HY, Hertz-Picciotto I, Sovcikova E, Kocan A, Trnovec T. WITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort. Neurotoxicology. 2009 Jul 30; doi: 10.1016/j.neuro.2009.07.015. Epub 2009 Jul 30. PMID: 19647017.
Copy Download .nbib Format: NLM
Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Hlavinkova L, Li X, Van Kriekinge G, Trnovec P.
PMID: 27202257
Value Health. 2014 Nov;17(7):A634. doi: 10.1016/j.jval.2014.08.2274. Epub 2014 Oct 26.

No abstract available.

Cite
Hlavinkova L, Li X, Van Kriekinge G, et al. Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia. Value Health. 2014;17(7):A634doi: 10.1016/j.jval.2014.08.2274.
Hlavinkova, L., Li, X., Van Kriekinge, G., & Trnovec, P. (2014). Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A634. https://doi.org/10.1016/j.jval.2014.08.2274
Hlavinkova, L, et al. "Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A634. doi: https://doi.org/10.1016/j.jval.2014.08.2274
Hlavinkova L, Li X, Van Kriekinge G, Trnovec P. Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia. Value Health. 2014 Nov;17(7):A634. doi: 10.1016/j.jval.2014.08.2274. Epub 2014 Oct 26. PMID: 27202257.
Copy Download .nbib Format: NLM
Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Stetka R, Psenkova M, Ondrusova M, Hlavinkova L, Trnovec P.
PMID: 27202506
Value Health. 2014 Nov;17(7):A679. doi: 10.1016/j.jval.2014.08.2529. Epub 2014 Oct 26.

No abstract available.

Cite
Stetka R, Psenkova M, Ondrusova M, et al. Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings. Value Health. 2014;17(7):A679doi: 10.1016/j.jval.2014.08.2529.
Stetka, R., Psenkova, M., Ondrusova, M., Hlavinkova, L., & Trnovec, P. (2014). Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A679. https://doi.org/10.1016/j.jval.2014.08.2529
Stetka, R, et al. "Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A679. doi: https://doi.org/10.1016/j.jval.2014.08.2529
Stetka R, Psenkova M, Ondrusova M, Hlavinkova L, Trnovec P. Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings. Value Health. 2014 Nov;17(7):A679. doi: 10.1016/j.jval.2014.08.2529. Epub 2014 Oct 26. PMID: 27202506.
Copy Download .nbib Format: NLM
Informacia o niektorych vysledkoch z Pilotnej studie projektu Ministerstva zdravotnictva SR. AUDIT diagnostickeho a terapeutickeho postupu u chorych s akutnymi koronarnymi syndromami.

Bratislavske lekarske listy

Cagan S, Wimmerova S, Trnovec T.
PMID: 9664743
Bratisl Lek Listy. 1998 Mar;99(3):202-5.

The basic analysis of the Pilot study fully confirms the possibilities of the realization of the project AUDIT ... in the planned form, the necessity to realize this project regarding the discovery of several negative facts in the management...

Cite
Cagan S, Wimmerova S, Trnovec T. Informacia o niektorych vysledkoch z Pilotnej studie projektu Ministerstva zdravotnictva SR. AUDIT diagnostickeho a terapeutickeho postupu u chorych s akutnymi koronarnymi syndromami. Bratisl Lek Listy. 1998;99(3):202-5
Cagan, S., Wimmerova, S., & Trnovec, T. (1998). Informacia o niektorych vysledkoch z Pilotnej studie projektu Ministerstva zdravotnictva SR. AUDIT diagnostickeho a terapeutickeho postupu u chorych s akutnymi koronarnymi syndromami. Bratislavske lekarske listy, 99(3), 202-5.
Cagan, et al. "Informacia o niektorych vysledkoch z Pilotnej studie projektu Ministerstva zdravotnictva SR. AUDIT diagnostickeho a terapeutickeho postupu u chorych s akutnymi koronarnymi syndromami." Bratislavske lekarske listy vol. 99,3 (1998): 202-5.
Cagan S, Wimmerova S, Trnovec T. Informacia o niektorych vysledkoch z Pilotnej studie projektu Ministerstva zdravotnictva SR. AUDIT diagnostickeho a terapeutickeho postupu u chorych s akutnymi koronarnymi syndromami. Bratisl Lek Listy. 1998 Mar;99(3):202-5. Czech. PMID: 9664743.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries